Eluminex Biosciences Funding: $100M Raised, Series B (2023)
Eluminex Biosciences is based in Suzhou, China. It has raised $100M in total funding. Latest round: Series B.
Eluminex Biosciences funding overview
Eluminex Biosciences is based in Suzhou, China. Eluminex Biosciences has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in August 2023. The round record for Eluminex Biosciences runs through 2023; nothing later has been disclosed. Investors on record include Lilly Asia Ventures, Hillhouse Capital, Quan Capital. 3 distinct backers are named across the disclosed rounds.
Eluminex Biosciences at a glance
Total raised
$100M
Latest round
Series B
Latest round date
August 2023
Headquarters
Suzhou, China
Notable investors
Lilly Asia Ventures, Hillhouse Capital, Quan Capital
Frequently asked about Eluminex Biosciences funding
How much has Eluminex Biosciences raised?
Eluminex Biosciences has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Eluminex Biosciences?
Lilly Asia Ventures, Hillhouse Capital, Quan Capital are named among the investors backing Eluminex Biosciences.
What was the latest Eluminex Biosciences funding round?
The most recent disclosed round is a Series B, announced in August 2023.
Where is Eluminex Biosciences based?
Eluminex Biosciences is based in Suzhou, China.
When did Eluminex Biosciences last raise?
The last disclosed Eluminex Biosciences round closed in August 2023 at Series B.
Totals shown for Eluminex Biosciences aggregate every disclosed round on file. To see how that compares, browse the companies in Suzhou and the investors behind them below.
